文献速递消化道肿瘤与早癌消化内镜

老年I期结肠癌患者术后监测性结肠镜与结肠癌特异性死亡率的关联

Surveillance Colonoscopy in Older Stage I Colon Cancer Patients and the Association With Colon Cancer-Specific Mortality.
PubMed 文献 · Am J Gastroenterol · 2020-01-01

该回顾性队列研究基于SEER数据库联合Medicare理赔数据,纳入8783例I期结肠癌患者,评估癌症导向手术后5年内监测性结肠镜与结肠癌特异性死亡率的关系。结果显示,与接受1次结肠镜者相比,未接受结肠镜者10年结肠癌特异性死亡率升高(HR=1.63;95%CI 1.31-2.04),接受≥2次结肠镜者10年结肠癌特异性死亡率降低(HR=0.60;95%CI 0.45-0.79),5年结果与10年相似。

要点

  • I期结肠癌术后未行监测性结肠镜与10年结肠癌特异性死亡率升高相关(HR=1.63)。
  • 接受≥2次监测性结肠镜与10年结肠癌特异性死亡风险降低相关(HR=0.60)。
  • 结果支持确保I期结肠癌患者术后接受监测性结肠镜以早期发现新发或复发肿瘤。

核心结论

  • 在老年I期结肠癌患者中,癌症导向手术后接受监测性结肠镜与结肠癌特异性死亡率降低相关,支持术后监测性结肠镜检查。

研究设计与样本

  • 回顾性队列研究,基于SEER数据库联合Medicare理赔数据,纳入8783例结肠癌病例。
  • 监测性结肠镜作为时间变化暴露,评估术后5年内无结肠镜、1次结肠镜和≥2次结肠镜三组。
  • 采用逆概率治疗加权平衡协变量,使用时依Cox回归模型获得加权风险比(HR)及95%置信区间(CI)。

主要发现

  • 与接受1次结肠镜者相比,无结肠镜组10年结肠癌特异性死亡率升高(HR=1.63;95%CI 1.31-2.04),非癌死亡风险亦升高(HR=1.36;95%CI 1.25-1.49)。
  • 与接受1次结肠镜者相比,≥2次结肠镜组10年结肠癌特异性死亡风险降低(HR=0.60;95%CI 0.45-0.79),其他癌症死亡风险降低(HR=0.68;95%CI 0.53-0.88),非癌死亡风险降低(HR=0.69;95%CI 0.62-0.76)。
  • 5年病因特异性HR与10年估计值相似。

临床怎么用

  • 对于I期结肠癌患者,癌症导向手术后应确保其接受监测性结肠镜检查,以促进早期发现新发和复发肿瘤性病变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Guideline-issuing groups differ regarding the recommendation that patients with stage I colon cancer receive surveillance colonoscopy after cancer-directed surgery. This observational comparative effectiveness study was conducted to evaluate the association between surveillance colonoscopy and colon cancer-specific mortality in early stage patients. METHODS: This was a retrospective cohort study of the Surveillance, Epidemiology, and End Results database combined with Medicare claims. Surveillance colonoscopy was assessed as a time-varying exposure up to 5 years after cancer-directed surgery with the following groups: no colonoscopy, one colonoscopy, and ≥ 2 colonoscopies. Inverse probability of treatment weighting was used to balance covariates. The time-dependent Cox regression model was used to obtain inverse probability of treatment weighting-adjusted hazard ratios (HRs), with 95% confidence intervals (CIs) for 5- and 10-year colon cancer, other cancer, and noncancer causes of death. RESULTS: There were 8,783 colon cancer cases available for analysis. Overall, compared with patients who received one colonoscopy, the no colonoscopy group experienced an increased rate of 10-year colon cancer-specific mortality (HR = 1.63; 95% CI 1.31-2.04) and noncancer death (HR = 1.36; 95% CI 1.25-1.49). Receipt of ≥ 2 colonoscopies was associated with a decreased rate of 10-year colon cancer-specific death (HR = 0.60; 95% CI 0.45-0.79), other cancer death (HR = 0.68; 95% CI 0.53-0.88), and noncancer death (HR = 0.69; 95% CI 0.62-0.76). Five-year cause-specific HRs were similar to 10-year estimates. DISCUSSION: These results support efforts to ensure that stage I patients undergo surveillance colonoscopy after cancer-directed surgery to facilitate early detection of new and recurrent neoplastic lesions.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Hines RB, Jiban MJH, Specogna AV, et al. Surveillance Colonoscopy in Older Stage I Colon Cancer Patients and the Association With Colon Cancer-Specific Mortality. Am J Gastroenterol. 2020. PMID: 32142485. doi:10.14309/ajg.0000000000000537

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。